Recent advances of microRNA participate in the process of thyroid carcinoma

  • TAN Can-Liang ,
  • LIU Li-Xin
Expand
  • 1.The Third Medical College of Southern Medical University, Guangzhou 510515, China;2.Department of general surgery, the Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China

Received date: 2014-10-08

  Online published: 2014-12-04

Cite this article

TAN Can-Liang , LIU Li-Xin . Recent advances of microRNA participate in the process of thyroid carcinoma[J]. Chinese Journal of Clinical Anatomy, 2014 , 32(6) : 744 -746 . DOI: 10.13418/j.issn.1001-165x.201

References


[1]  Mackenzie EJ, Mortimer RH. Thyroid nodules and thyroid cancer
[J]. Med J Aust, 2004, 180(5): 242-247.

[2] Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA
[J]. Proc Natl Acad Sci USA, 2006,103(11): 4034-4039.

[3]  Chen CZ,Li L,Lodish HF,et al. MicroRNAs modulate hematopoietic lineage differentiation
[J]. Science, 2004, 303(5654): 83-86.

[4]  Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function
[J]. Cell, 2004,116(2): 281-297.

[5]  Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
[J]. Cell, 1993, 75(5): 843-854.

[6]  Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
[J]. Nature, 2000, 403(6772): 901-906.

[7] Lewis BP, Burge CB, Bartel DP. Conservedseed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
[J]. Cell, 2005, 120(1): 15-20.

[8] Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer
[J]. Nat Rev Cancer, 2006, 6(4):259-269.

[9] He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma
[J]. Proc Natl Acad Sci USA, 2005, 102(52):19075-19080.

[10] Pallante P, Visone R,Croce CM, et al. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas
[J]. Endocr Relat Cancer, 2010,17(1): F91-104.

[11]Pallante P, Visone R, Ferracin M, et al. MicroRNA deregulation in human thyroid papillary carcinomas
[J]. Endocr Relat Cancer, 2006,13(2): 497-508.

[12] Mazeh H, Mizrahi I, Halle D, et al. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples
[J]. Thyroid, 2011, 21(2): 111-118.

[13]Lee JC, Zhao JT, Clifton-Bligh RJ, et al. MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
[J]. Cancer, 2013, 119(24): 4358-4365.

[14] Chou CK, Chen RF, Chou FF, et al. miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation
[J]. Thyroid, 2010, 20(5): 489-494.

[15] Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
[J]. J Exp Med, 1996, 184(3): 1101-1109.

[16] Castellone MD, Guarino V, De Falco V, et al. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas
[J]. Oncogene, 2004, 23(35):5958-5967.

[17] Nasser MW, Datta J, Nuovo G, et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1
[J]. Biol Chem, 2008, 283(48): 33394-33405.

[18]Lin JD, Chao TC. Follicular thyroid carcinoma: From diagnosis to treatment
[J]. Endocr , 2006, 53(4): 441-448.

[19] Weber F, Teresi RE, Broelsch CE, et al. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma
[J]. Clin Endocrinol Metab, 2006, 91(9): 3584-3591.

[20]Nikiforova MN, Chiosea SI, Nikiforov YE. MicroRNA expression profiles in thyroid tumors
[J]. Endocr Pathol, 2009, 20(2): 85-91.

[21] Nikiforova MN, Tseng GC, Steward D, et al. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility
[J]. Clin Endocrinol Metab, 2008, 93(5):1600-1608.

[22] Rossing M, Borup R, Henao R, et al. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma
[J]. Mol Endocrinol, 2012, 48(1):11-23.

[23] Abraham D, Jackson N, Gundara JS, et al. MicroRNA  profiling  of sporadic and hereditary medullary thyroid cancer identifies preditors of nodal metastasis,prognosis,and potential therapeutic targets
[J]. Clin Cancer Res, 2011, 17(14):4772-4781.

[24] Takakura S, Mitsutake N, Nakashima M, et al. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
[J]. Cancer Sci, 2008, 99(6):1147-1154.

[25] Visone R, Pallante P, Vecchione A, et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
[J]. Oncogene, 2007, 26(54):7590-7595.

Options
Outlines

/